Psychemedics Corporation (PMD)
NASDAQ: PMD
· Real-Time Price · USD
2.67
0.00 (0.00%)
At close: Jun 17, 2025, 10:00 PM
Psychemedics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 19.68M | 20.26M | 20.79M | 21.6M | 22.1M | 22.8M | 23.61M | 24.59M | 25.24M | 25.97M | 26.13M | 25.7M | 24.91M | 23.81M | 22.31M | 19.54M |
Cost of Revenue | 12.58M | 12.49M | 12.96M | 13.27M | 13.69M | 14.2M | 14.77M | 15.54M | 15.95M | 16.74M | 16.16M | 15.57M | 14.64M | 14.45M | 14.89M | 14.81M |
Gross Profit | 7.1M | 7.77M | 7.82M | 8.33M | 8.41M | 8.6M | 8.84M | 9.05M | 9.29M | 9.23M | 9.97M | 10.14M | 10.26M | 9.36M | 7.41M | 4.73M |
Operating Income | -1.89M | -2.93M | -3.44M | -2.96M | -2.92M | -2.41M | -1.68M | -1.6M | -1.08M | -1.69M | -467K | 82K | 209K | 65K | -2.19M | -5.71M |
Interest Income | n/a | n/a | n/a | 5K | 5K | 37K | 37K | 32K | 32K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -1.92M | -2.95M | -3.45M | -3.48M | -3.44M | -2.92M | -2.2M | -1.63M | -1.04M | -2.73M | -1.43M | -869K | -822K | 115K | -2.24M | -5.79M |
Net Income | -1.86M | -3M | -4.56M | -4.46M | -4.15M | -3.9M | -1.9M | -1.51M | -1.08M | -2.02M | -1.18M | -709K | -665K | 413K | -1.43M | -3.62M |
Selling & General & Admin | 8.24M | 9.85M | 10.31M | 10.23M | 10.19M | 9.83M | 9.28M | 9.35M | 9.05M | 9.61M | 9.21M | 8.89M | 8.93M | 8.18M | 8.43M | 9.2M |
Research & Development | 749K | 855K | 958K | 1.05M | 1.14M | 1.18M | 1.24M | 1.31M | 1.33M | 1.32M | 1.23M | 1.17M | 1.13M | 1.12M | 1.18M | 1.23M |
Other Expenses | -3K | -4K | -4K | -9K | -11K | -16K | -24K | -28K | -23K | -17K | -9K | n/a | -14K | -25K | -42K | -42K |
Operating Expenses | 8.99M | 10.7M | 11.26M | 11.29M | 11.33M | 11.01M | 10.52M | 10.66M | 10.37M | 10.92M | 10.44M | 10.05M | 10.05M | 9.29M | 9.61M | 10.43M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 6K | 14K | 23K | 23K | 2.18M | 2.18M | 2.17M | 2.18M | 25K | 42K | 81K |
Selling & Marketing Expenses | 2.55M | 2.68M | 2.83M | 2.9M | 3M | 3.04M | 3.11M | 3.17M | 3.19M | 3.26M | 3.12M | 2.96M | 2.8M | 2.67M | 2.91M | 3.11M |
Cost & Expenses | 21.58M | 23.19M | 24.23M | 24.55M | 25.02M | 25.21M | 25.29M | 26.19M | 26.32M | 27.66M | 26.6M | 25.62M | 24.7M | 23.74M | 24.5M | 25.24M |
Income Tax Expense | -55K | 43K | 1.11M | 981K | 716K | 973K | -305K | -122K | 44K | -718K | -246K | -160K | -157K | -298K | -803K | -2.17M |
Shares Outstanding (Basic) | 5.89M | 5.89M | 5.82M | 5.81M | 5.81M | 5.75M | 5.71M | 5.68M | 5.73M | 5.64M | 5.61M | 5.59M | 5.59M | 5.54M | 5.54M | 5.54M |
Shares Outstanding (Diluted) | 5.89M | 5.89M | 5.82M | 5.81M | 5.81M | 5.75M | 5.71M | 5.68M | 5.73M | 5.64M | 5.61M | 5.65M | 5.59M | 5.63M | 5.63M | 5.64M |
EPS (Basic) | -0.32 | -0.51 | -0.78 | -0.77 | -0.72 | -0.68 | -0.33 | -0.26 | -0.19 | -0.36 | -0.21 | -0.13 | -0.13 | 0.06 | -0.27 | -0.66 |
EPS (Diluted) | -0.32 | -0.51 | -0.78 | -0.77 | -0.72 | -0.68 | -0.33 | -0.26 | -0.19 | -0.36 | -0.21 | -0.13 | -0.13 | 0.06 | -0.27 | -0.66 |
EBITDA | -267K | -1.14M | -962K | -448K | -241K | 449K | 1.32M | 1.57M | 2.23M | 629K | 2.04M | 2.63M | 2.81M | 3.8M | 1.46M | -2.09M |
EBIT | -1.89M | -2.93M | -3.44M | -2.96M | -2.92M | -2.41M | -1.68M | -1.6M | -1.08M | -1.69M | -467K | 82K | 209K | 65K | -2.19M | -5.71M |
Depreciation & Amortization | 1.63M | 1.79M | 2.48M | 2.51M | 2.67M | 2.86M | 3M | 3.17M | 3.32M | 3.41M | 3.59M | 3.64M | 3.69M | 3.75M | 3.67M | 3.66M |